Virus purification
Inventors
Barbero Calzado, Jana • Nebenführ, Mario • Schiegl, Robert • Weber, Michael • HEINDL-WRUSS, Jürgen
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.
Core Innovation
The described method addresses impurities in a crude harvest of infectious Chikungunya virus particles generated during growth on a cell substrate. The process combines impurity reduction using an agent comprising protamine with subsequent sucrose density gradient centrifugation. This separation isolates the Chikungunya virus preparation and separates protamine from the virus fraction, while [procedural detail omitted for safety].
The disclosure indicates that protamine treatment removes aggregates and non-infectious particles while retaining infectious titre, enhancing recovery by disrupting DNA–virus interactions. In Vero-cell-derived harvests, protamine-treated viral material yields purified fractions with estimated purity above 95% and approximately 70% step yield, whereas Benzonase-treated material co-purifies with host-cell proteins.
Claims Coverage
The claims identify one independent claim comprising three inventive features directed to the purification of infectious Chikungunya virus particles.
Impurity reduction in a crude harvest
The method reduces impurities generated during growth of virus particles on a cell substrate by treatment with an agent comprising protamine.
Density-based purification of the virus preparation
The method purifies the virus preparation by sucrose density gradient centrifugation, separating protamine from the Chikungunya virus fraction, wherein [procedural detail omitted for safety].
Purified Chikungunya virus preparation
The claimed method yields a Chikungunya virus preparation having a protamine concentration below a designated threshold, wherein [procedural detail omitted for safety].
The independent claim combines protamine-based impurity reduction with sucrose density gradient centrifugation to obtain a purified Chikungunya virus preparation separated from protamine.
Stated Advantages
The reported approach yields purified virus fractions and is described as effective for virus purification.
The text indicates improved gradient recovery through disruption of DNA–virus interactions.
The reported gradient separation enriches virus and separates it from protamine and residual contaminants.
Protamine treatment preferentially removes aggregates and non-infectious particles while retaining infectious titre.
The reported gradient pool achieves estimated purity above 95% and approximately 70% step yield.
The disclosure reports reduced residual protamine in the virus preparation.
The disclosure reports improved purification yield for vaccine production.
Documented Applications
Purification of infectious Chikungunya virus particles from a crude harvest containing impurities generated during growth on a cell substrate.
Purification approach applied to Zika virus and yellow fever virus.
Production of virus vaccines.
Interested in licensing this patent?